The ligand for CD40 is expressed on activated T lymphocytes and delivers contact-dependent 
Introduction
Humoral immunity is critically dependent on interaction between T and B lymphocytes. T cells secrete cytokines necessary for B cell differentiation and activate B cells in a contact-dependent manner (1) . A prime candidate for the T cell surface molecule that delivers the contact-dependent signal is the recently described ligand for the B cell antigen CD40 (2) (3) (4) (5) . The CD40 ligand (CD40L)' is a 39-kD type II membrane glycoprotein expressed on activated T cells. It is homologous to tumor necrosis factor (4) , while its counterreceptor on B cells, CD40, is a member of the tumor necrosis factor receptor/nerve 1 . Abbreviations used in this paper: [Ca2+ ] i, intracellular calcium; CD40L, CD40 ligand; CsA, cyclosporin A; IL-2Ra, IL-2 receptor alpha chain; NF-AT, nuclear factor of activated T cells; PKC, protein kinase C; sCD40, soluble CD40. growth factor receptor family (6) . Engagement of CD40 on B cells by monoclonal antibody or by CD40L results in B cell activation, proliferation, aggregation, and immunoglobulin isotype switching (2, 4, (7) (8) (9) (10) (11) . Soluble forms of CD40 (sCD40) inhibit T cell-dependent B cell activation and immunoglobulin isotype switching (3, 12) . We ( 13, 14) and others (15) (16) (17) (18) have recently reported that a defect in the gene encoding CD40L is responsible for X-linked immunoglobulin deficiency with normal or elevated IgM (X-linked hyper IgM). These patients are unable to synthesize immunoglobulins other than IgM or IgD ( 19, 20) , suggesting that interaction between CD40 on B cells and its ligand on activated T cells is critical for immunoglobulin isotype switching. They also suffer from recurrent infections, particularly Pneumocystis carinji pneumonia, autoimmune disease, and lymphoproliferative disease (21 ). The role ofCD40L in preventing these diseases is unknown. An understanding ofthe mechanisms regulating the expression of CD40L in T cells is essential to define its role in the immune response. In this report, we demonstrate that activation ofprotein kinase C (PKC) and ofcalcineurin is required for CD40L gene expression and that cyclosporin A (CsA) inhibits CD40L gene expression and CD40L-dependent T cell function.
Methods
Cells and reagents. PBMC and T cells were isolated from healthy volunteers or from transplant patients receiving CsA as previously described ( 1 ) . T cells were > 98% CD3 positive as determined by flow cytometry. PMA, 20 ng/ml, and ionomycin, 0.5 ,gM, were obtained from Calbiochem-Novabiochem Corp. (San Diego, CA). CsA was kindly provided by Sandoz Inc. (East Hanover, NJ). CsA analogues MeBm2t '-CsA and MeAla6-CsA were previously described (22) .
Cell surface staining andflow cytometry. Cell surface staining for CD40L was performed 6 h after stimulation, unless otherwise indicated, using sCD40, a product of fusion of cDNA segments encoding the extracellular domain of CD40 (6) to genomic DNA segments encoding human IgG, (3) as previously described ( 13 IgE assay. Induction ofIgE synthesis was performed and assayed as previously described (1) . PBMC were stimulated with 5 ng/ml recombinant IL4 (R&D Systems, Inc., Minneapolis, MN) or with IL-4 plus 5 /g/ml CD40 mAb 626.1 (25) (gift of Dr. S. M. Fu, University of Virginia School ofMedicine, Charlottesville, VA). 100 ng/ml CsA was added to the cultures as indicated. Culture supernatants were collected on day 10 and assayed for IgE as described ( 1) . Background IgE levels were detected in the presence of 100 Ag/ml cycloheximide and were always < 500 pg/ml. The average of two replicate samples is given in the results and represents net IgE synthesis above background.
Patients. Three patients receiving CsA were studied after obtaining informed consent. The first patient (CsA patient 1) was a 12-yr-old male who was studied before a kidney transplant. PBMC were derived from blood samples obtained before and 3 h after a single dose of 4 mg/kg CsA. He had not received any other immunosuppressant at the time of the study. CsA patient 2 was a 19-yr-old female, and CsA patient 3 was a 15-yr-old male, both of whom were receiving CsA after kidney transplantation and, at the time of the study, had trough blood CsA levels of 124 and 84 ng/ml (whole blood HPLC), respectively. Both patients were also receiving 15 mg prednisone every other day. Control subjects included healthy adults and a 20-yr-old female asthmatic patient who was receiving 15 mg of prednisone every other day.
Results

Activation ofT cells via the T cell receptor (antigen receptor)/
CD3 complex results in a signaling cascade leading to the phosphorylation ofphospholipase Cy on tyrosine residues (26-28). Phospholipase C-y initiates the hydrolysis ofphosphatidylinositol bisphosphate into diacylglycerol and inositol trisphosphate (29, 30) (34) , resulted in minimal expression of CD40L (' 6%). Maximal expression of CD40L (> 60%) occurred upon stimulation with both PMA and ionomycin, indi- cating that activation of PKC and a rise in [Ca2+]i are required for optimal expression of CD40L. Fig. 1 A shows that CD40L can be detected on the surface of T cells as early as 3 h after stimulation with PMA and ionomycin. CD40L surface expression peaked at 6 h after stimulation, started to decline by 8 h, and was barely detectable by 16 h. Northern blot analysis of PMA-and ionomycin-induced CD40L mRNA in T cells is shown in Fig. 1 B. CD40L mRNA was detected as early as 1 h after stimulation, peaked at 3 h, and had decreased by 6 h after stimulation, consistent with the kinetics of CD40L surface expression.
The increase in [Ca2"]i that results from engagement ofthe T cell receptor/CD3 complex causes the activation of Ca2"/ calmodulin-dependent enzymes including the protein phosphatase calcineurin. Calcineurin plays a key role in signal transduction in T cells (35, 36) . Calcineurin dephosphorylates the cytoplasmic subunit ofthe transcription factor, nuclear factor ofactivated T cells (NF-AT) (37, 38) , which translocates to the nucleus where together with other proteins it forms a functionally active NF-AT complex that regulates the transcription ofthe IL-2 gene (39) . The activity ofcalcineurin can be modulated by complexes of immunosuppressant drugs and their endogenous immunophilins, a family of proteins which bind immunosuppressants. One such immunosuppressant is CsA, a natural microbial product which binds to cyclophilin (40) . The CsA/cyclophilin complex binds to calcineurin and inhibits its phosphatase activity (41, 42) . To evaluate the role of calcineurin in the signal transduction pathway leading to the expression of CD40L, we examined the effect of CsA on the expression of CD40L in T cells. Fig. 2 shows that increasing concentrations of CsA inhibited the surface expression of CD40L induced by PMA and ionomycin. Peak inhibition of CD40L surface expression occurred at a concentration of 100 ng/ml of CsA, with no further inhibition detected at higher concentrations. In contrast, CsA did not affect the surface expression of IL-2Ra, except for a minimal decrease in the mean fluorescence intensity ofIL-2Ra at high concentrations ofCsA. CsA inhibited the induction of CD40L mRNA induced by PMA and ionomycin (Fig. 3) . As previously reported (43) , CsA inhibited the expression of IL-2 mRNA. Peak inhibition ofCD40L and IL-2 mRNA by CsA occurred at a concentration of 100 ng/ml. The induction of both 3.5-and 1.5-kb IL-2Ra mRNA transcripts (44, 45) by PMA and ionomycin was minimally affected by CsA except at higher concentrations. Since mRNA was obtained at 3 h, the inhibition of IL-2Ra mRNA was probably due to inhibition by CsA (46) of its receptor (47) . Inhibition of CD40L expression by CsA was not due to inhibition of IL-2 expression because addition ofIL-2 (100 U /ml) did not reverse CsA-mediated inhibition of CD40L mRNA or surface expression (data not shown).
The role of calcineurin in CD40L expression was further investigated using analogues of CsA with different affinities for cyclophilin and calcineurin. MeBm2t '-CsA, which has a much lower affinity for cyclophilin than CsA (K, 500 nM vs 6.0) but whose cyclophilin complex has a higher affinity for calcineurin (Ki 13 nM vs 40) (22), inhibited PMA-and ionomycin-induced CD40L surface expression (Fig. 4) . MeBm2t'-CsA at 150 ng/ml almost completely inhibited PMA-and ionomycininduced CD40L expression and therefore was only slightly less active than CsA despite an 80-90-fold weaker affinity for cyclophilin. MeAla6-CsA, which has a slightly lower affinity for cyclophilin than CsA (Ki 9.0 nM vs 6.0) but whose cyclophilin complex has a much lower affinity for calcineurin (K, > 1 x 103 nM vs 40) (22), did not inhibit PMA-and ionomycininduced CD40L surface expression even at concentrations as high as I ,ug/ml (Fig. 4) . These results indicate that calcineurin 2 has a direct role in the signaling pathway regulating CD40L expression.
The functional importance of CsA-induced inhibition of CD40L expression was investigated by assessing the effect of CsA on immunoglobulin isotype switching to IgE. IL-4-induced IgE isotype switching in PBMC is T cell dependent (1) and is inhibited by sCD40 (12) , indicating that CD40L expression by T cells plays a critical role in T cell-dependent IL-4-driven IgE isotype switching. Table I shows that CsA inhibited T cell-dependent IL-4-induced IgE synthesis in PBMC derived from three different individuals. The effect of CsA was exerted at the T cell level because CsA did not inhibit T cell-independent IgE synthesis induced by CD40 mAb and IL-4. Therefore inhibition ofCD40L expression by CsA is associated with inhibition of CD40L-mediated T cell-dependent B cell function.
Finally, we investigated CD40L expression in PBMC derived from CsA-treated transplant recipients. One patient was studied before and 3 h after the administration of a single dose of 4 mg/kg CsA within the period when blood CsA levels peak, 2-4 h after oral administration (48) . Fig. 5 A shows that PBMC derived from the patient before the administration of CsA expressed CD40L after stimulation with PMA and ionomycin. Administration of a single dose of CsA inhibited, within 3 h, CD40L expression in PBMC. This effect was selective to CD40L because administration of CsA did not inhibit PMAand ionomycin-induced IL-2Ra expression. Two other kidney transplant patients who were receiving CsA and low dose alternate day prednisone were also studied. In contrast to PBMC derived from healthy adult subjects or from an asthmatic patient receiving equivalent doses of alternate day steroids, PBMC derived from the transplant patients receiving CsA and alternate day steroids failed to express CD40L on their surface upon stimulation with PMA and ionomycin (Fig. 5 B) . PBMC from patients and controls expressed IL-2Ra normally. Therefore, administration ofCsA in vivo inhibits PMA-and ionomycin-induced CD40L expression in PBMC. sion by 60% at 100 ng/ml (data not shown) and by 85%
at 150 ng/ml. However, MeAla6-CsA did not inhibit CD40L expression at concentrations ranging from 100 ng/ml to 1 zg/ml (data for 1 jlg/ml shown Experiments involving overexpression of calcineurin in Jurkat T cells suggest that NF-AT is a target of calcineurin (35) . More recently, NF-AT has been shown to be a substrate for calcineurin in vitro (38) . It is therefore likely that NF-AT may play an important role in the regulation oftranscription of the CD40L gene. A role for NF-AT may also explain the requirement for activation of PKC. PKC activates several nuclear transcription factors including members of the fos and jun family ofproteins which participate in a functional NF-AT 
